老年患者髋关节置换术后静脉自控镇痛中右美托咪定复合舒芬太尼的应用价值

发布时间：2017-12-28 16:26

本文关键词：老年患者髋关节置换术后静脉自控镇痛中右美托咪定复合舒芬太尼的应用价值　出处：《世界最新医学信息文摘》2016年96期 　论文类型：期刊论文

【摘要】：目的探究右美托咪定联合舒芬太尼在老年患者髋关节置换术中静脉自控镇痛的效果,评估其临床应用价值。方法将我院接收的髋关节置换术老年患者62例作为研究对象,按随机数字表法将其分为对照组(30例,给予舒芬太尼加格拉司琼进行麻醉)和治疗组(32例,给予舒芬太尼联合右美托咪定加托烷司琼麻醉)。结果治疗组与对照组术后30min内VAS疼痛评分无明显差异(P0.05),术后2h、4h、24h VAS疼痛评分明显低于对照组,差异有统计学意义(P0.05);治疗组与对照组术后不良反应发生率分别为3.13%、13.33%,差异有统计学意义(P0.05)。结论联合应用舒芬太尼与右美托咪定对髋关节置换术术后镇痛效果良好,阿片类受体用药剂量小,不良反应发生率低,临床应用价值较高。
[Abstract]:Objective to investigate the effect of dexmedetomidin combined with sufentanil on intravenous self controlled analgesia in elderly patients with hip replacement, and to evaluate its clinical value. Methods in our hospital received hip replacement in elderly patients 62 cases as the research object, randomly divided into control group (30 cases, given sufentanil anesthesia ghagra granisetron) and treatment group (32 cases, given sufentanil combined with dexmedetomidine gatto tropisetron anesthesia). Results there was no difference between the treatment group and the control group 30min postoperative VAS pain score (P0.05), 2h, 4h, 24h, VAS postoperative pain score was significantly lower than the control group, the difference was statistically significant (P0.05); the treatment group and the control group the incidence of postoperative adverse reactions were 3.13% and 13.33%, the difference was statistically significant (P0.05). Conclusion combined application of sufentanil and dexmedetomidine has good analgesic effect after total hip arthroplasty. Opioid receptor dose is low, the incidence of adverse reactions is low, and its clinical application value is high.
【作者单位】：广西灵山县中医医院麻醉科;
【分类号】：R614
【正文快照】： 0引言老年患者行髋关节置换术后会发生剧烈疼痛,对其术后产生不良影响,给予患者好的镇痛方法,有助于患者预后[1]。本研究应用右美托咪定联合舒芬太尼对老年髋关节置换术给予静脉自控镇痛,效果良好,阐述如下。1资料与方法1.1临床资料。1.1.1选择对象。选取我院2014年3月至2015

【相似文献】